Impact of a ketogenic diet on metabolic parameters in patients with obesity or overweight and with or without type 2 diabetes: a meta-analysis of randomized controlled trials.
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index; 15 of the 52 sources its claims cite were checked for support.
Abstract
The aim of this meta-analysis was to explore the efficacy of a ketogenic diet in metabolic control in patients with overweight or obesity and with or without type 2 diabetes. Embase, PubMed, and Cochrane Library were searched for randomized controlled trials that enrolled patients with overweight or obesity on a ketogenic diet for metabolic control. Fourteen studies were included in meta-analysis. The effects of ketogenic diets on glycemic control were greater for diabetic patients relative to those of low-fat diets, indicated by lower glycated hemoglobin (SMD, −0.62; p < 0.001) and homeostatic model assessment index (SMD, −0.29; p = 0.02), while comparable effects were observed for nondiabetic patients. Ketogenic diets led to substantial weight reduction (SMD, −0.46; p = 0.04) irrespective of patients’ diabetes status at baseline and improved lipid profiles in terms of lower triglyceride (SMD, −0.45; p = 0.01) and greater high-density lipoprotein (SMD, 0.31; p = 0.005) for diabetic patients. Other risk markers showed no substantial between-group difference post intervention. Our study findings confirmed that ketogenic diets were more effective in improving metabolic parameters associated with glycemic, weight, and lipid controls in patients with overweight or obesity, especially those with preexisting diabetes, as compared to low-fat diets. This effect may contribute to improvements in metabolic dysfunction-related morbidity and mortality in these patient populations.
Overview
CoChat Summary
TL;DR
This meta-analysis of 14 RCTs found that ketogenic diets improved glycemic control, weight loss, and some lipid parameters in patients with overweight/obesity, especially those with preexisting type 2 diabetes, compared with low-fat-based comparator diets. Effects on blood pressure, CRP, and serum creatinine were comparable to comparator diets.
Key findings
- In diabetic patients, ketogenic diets lowered HbA1c (SMD, −0.62; 95% CI, −0.89 to −0.35; p < 0.001; I² = 0%) and HOMA index (SMD, −0.29; 95% CI, −0.54 to −0.04; p = 0.02; I² = 0%) versus comparator diets; nondiabetic patients showed no significant glycemic decrease.
- Overall, ketogenic diets lowered fasting glucose (SMD, −0.25; 95% CI, −0.50 to −0.00; I² = 52%) and HbA1c (SMD, −0.48; 95% CI, −0.69 to −0.27; I² = 23%); mean between-group HbA1c changes were −0.5% in diabetic patients and −0.42% overall (both p < 0.001).
- Weight reduction was greater with ketogenic diets (SMD, −0.46; 95% CI, −0.90 to −0.03; I² = 78%); mean between-group weight changes were −7.78 kg in diabetic patients and −3.81 kg overall. BMI and waist circumference reductions approached but did not reach significance (p = 0.08 and p = 0.09).
- In diabetic patients, ketogenic diets lowered triglycerides (SMD, −0.45; 95% CI, −0.80 to −0.10; I² = 59%) and raised HDL (SMD, 0.31; 95% CI, 0.10 to 0.52; I² = 0%); in nondiabetic patients, total cholesterol (SMD, 0.34; 95% CI, 0.08 to 0.61) and LDL (SMD, 0.35; 95% CI, 0.09 to 0.61) increased. Other risk markers showed no substantial between-group difference.
Methods
- PRISMA-guided systematic review and meta-analysis; Embase, PubMed, and Cochrane Library searched through 11 February 2020 for RCTs of ketogenic diets in patients with overweight or obesity, with or without type 2 diabetes, versus comparator diets (primarily low-fat-based).
- Fourteen RCTs were included, enrolling 734 participants: 444 diabetic patients and 290 nondiabetic patients; intervention durations varied across outcomes (e.g., 3–12 months for glycemic control, 4 weeks–12 months for weight, and 4 days–2 years for lipids).
- Continuous outcomes were pooled as weighted standardized mean differences with 95% CIs; fixed- or random-effects models were chosen based on I²; subgroup analyses were performed by baseline type 2 diabetes status; RevMan 5.3 was used, with Cochrane risk-of-bias and GRADE assessments and Begg’s/Egger’s tests for publication bias.
Limitations
- The paper states that included RCTs had different study designs and control diets (mostly low-fat-based), intervention durations varied, some subgroup analyses may have been underpowered due to small sample size, and surrogate markers were used rather than patient-important endpoints such as cardiovascular/renal events or mortality.
- Evident from the text: only one included study reported adverse effects; two studies had high risk of attrition bias and one had high risk of bias from baseline triglyceride imbalance; heterogeneity was high for weight (I² = 78%) and triglycerides (I² = 59%).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
9 Valid · 0 Not valid · 21 Not checked · 70 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In 2019, American Diabetes Association (ADA) newly endorsed low-carbohydrate diet as part of medical nutrition therapy options in diabetic patients based on the study results denoting enhanced glycemic control with a very low-carbohydrate diet inducing nutritional ketosis in T2DM patients [27,50,51,52].”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 4. Discussion
What the sources say
- Could not verifycites [27] Saslow, 2017, Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes, Nutr. Diabetes sourceExperimental — accuracy not yet measured
The Introduction and Discussion report the trial’s findings on glycemic control, but neither addresses an ADA endorsement. Searches for ADA recommendations and medical nutrition therapy found no passage about a 2019 decision; the cited paper was published in 2017. (LLM, conf=0.78)
- Not checked yetcites [50] Sainsbury, 2018, Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis, Diabetes Res. Clin. Pract. source
- Not checked yetcites [51] American Diabetes Association (2019). 5. Lifestyle management: Standards of medical care in diabetes-2019. Diabetes Care, 42, S46–S60. source
- Partly supportedcites [52] Hallberg, 2018, Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: An open-label, non-randomized, controlled study, Diabetes Ther. sourceExperimental — accuracy not yet measured
The Methods (Continuous Care Intervention) describe carbohydrate restriction to achieve nutritional ketosis, and the Discussion reports improved HbA1c after one year. The paper does not report a 2019 ADA endorsement or establish that the ADA acted based on these results. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“weight loss is reported to attenuate or reverse obesity-induced insulin resistance [48,49]”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 4. Discussion
What the sources say
- Supportedcites [48] Ye, 2013, Mechanisms of insulin resistance in obesity, Front. Med. source
The Abstract of Ye (2013) lists weight loss among 'the effective therapies such as weight loss, exercise, and caloric restriction [that] all reduce ATP in insulin sensitive cells', i.e. therapies that act on obesity-induced insulin resistance. The Summary (p. last section) states the energy-centred mechanism 'explains insulin sensitivity in response to weight loss, exercise, and caloric restriction where energy surplus is attenuated', and the Inflammation section notes 'Negative energy balance in the body has been known for long time to improve insulin sensitivity in the models of exercise, calorie restriction and weight loss'. The Mitochondrial dysfunction section also refers to 'improvement of insulin sensitivity from weight loss'. Together these support the attributed point that weight loss attenuates/reverses obesity-induced insulin resistance; the paper frames it as an established, reported effect rather than its own trial. (LLM, conf=0.86)
- Not checked yetcites [49] Vidal, 2002, Updated review on the benefits of weight loss, Int. J. Obes. Metab. Disord. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“nutritional ketosis has shown the capacity to reduce the use of hypoglycemic agents in diabetic patients [32,52]”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 4. Discussion
What the sources say
- Partly supportedcites [32] Westman, 2008, The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus, Nutr. Metab. sourceExperimental — accuracy not yet measured
Our copy supports the medication-reduction half: the Abstract Results (Results, p. n/a) state 'Diabetes medications were reduced or eliminated in 95.2% of LCKD vs. 62% of LGID participants (p < 0.01)', and the Discussion (and Conclusion) describe insulin elimination alongside improved glycemic control in overweight/obese adults with type 2 diabetes over 24 weeks. However, the paper attributes the effect to lower carbohydrate intake (significance remained after adjustment for weight loss, Discussion), not to nutritional ketosis as a mechanism — urinary ketones appear only as an adherence measure (Methods, 'Adherence'). The claim's generalisation to 'diabetic patients' also exceeds this source's type 2, adult, completer population. (LLM, conf=0.72)
- Supportedcites [52] Hallberg, 2018, Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: An open-label, non-randomized, controlled study, Diabetes Ther. source
Hallberg et al. (2018) is a 1-year T2D study whose intervention was explicitly built to achieve and sustain nutritional ketosis (Methods, Continuous Care Intervention: goal 0.5–3.0 mmol L−1 blood BHB). Its Results and Abstract report that usage of all diabetes medications excluding metformin fell from 56.9 ± 3.1% to 29.7 ± 3.0% (P < 1.0 × 10−16), with insulin reduced or eliminated in 94% of users and sulfonylureas entirely eliminated, versus no significant change in usual care. The Discussion (Effectiveness) states 'HbA1c improved concurrent with medication reductions prescribed for blood glucose-lowering,' tying the glycemic improvement under ketosis to the reduced agent use. The one nuance is that the source credits the multicomponent care model (including provider-managed downward titration) rather than isolating ketosis as the sole cause, but the attributed content — ketosis achieved in diabetic patients with markedly reduced hypoglycemic-agent use — is stated in our copy. (LLM, conf=0.82)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Our meta-analysis for glycemic control incorporated 4 studies [27,28,30,34] that had intervention duration of at least 8 months or longer”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 4. Discussion
What the sources say
- Supportedcites [27] Saslow, 2017, Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes, Nutr. Diabetes source
The citation identifies this trial as one of the four studies in the citing authors’ meta-analysis; the count of four is their own description, not a finding attributed to this paper. The Methods (Assessments) and Results (Table 1) show glycemic-control measurements, including HbA1c, at 12 months—longer than the stated eight-month minimum. (LLM, conf=0.91)
- Supportedcites [28] Saslow, 2017, An online intervention comparing a very low-carbohydrate ketogenic diet and lifestyle recommendations versus a plate method diet in overweight individuals with type 2 diabetes: A randomized controlled trial, J. Med. Internet Res. source
The Methods > Measures section describes this as a 32-week online dietary intervention with HbA1c measured at baseline, week 16, and week 32. That is approximately eight months, making this paper an appropriate citation for one of the studies described; it cannot establish the citing authors’ count of four studies. (LLM, conf=0.84)
- Not checked yetcites [30] Tay, 2018, Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial, Diabetes Obes. Metab. source
- Not checked yetcites [34] Yancy, 2010, A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss, Arch. Intern. Med. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In overall patients, the ketogenic diet appeared more effective in lowering FG (SMD, −0.25; 95% CI, −0.50 to −0.00; I2 = 52%; low quality evidence)”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 3. Results > 3.3. The Effects of a Ketogenic Diet on Glycemic Control
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
53 more claims
Create a free account to see all 100 claims and to verify the 37 references still open.
- Probably not a substantial claim. 27
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Seventeen meta-analyses were included (Fig. 1 and Additional file 2: Table S3) [1, 2, 15–17, 34–45].”
From Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“While some evidence demonstrates weight loss and improved CVD risk factors with other popular weight-loss approaches (eg, time-restricted eating, intermittent fasting, ketogenic diet),70–72 clinical practice guidelines have not endorsed these strategies, and they may require dietitian support.”
From Obesity Management in Adults: A Review (2023) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 4. Discussion
“The mean post-intervention improvement in triglyceride levels was −35.12 mg/dL (p = 0.002) and −20.65 mg/dL (p = 0.02) in overall patients.”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 3. Results > 3.5. The Effects of a Ketogenic Diet on Lipid Panel
“The mean between-group difference in triglyceride changes was −35.12 mg/dL (p = 0.002) in diabetic patients and −20.65 mg/dL (p = 0.02) in overall patients.”
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) was used to guide our methodology and to prepare this article [17,18].”
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 1×
“…low, and very low in e ff ect estimates for individual outcomes, based on the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, in which studies are evaluated on five aspects: precision, consistency of e ff ect, directness, risk of bias, and publication bias [19,20].”
MethodShamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120 · cited 1×
“The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) was used to guide our methodology and to prepare this article [17,18].”
MethodGrading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432 · cited 1×
“The current treatment guidelines for obesity recommend dietary restriction, specifically caloric restriction, as the first nutritional modification for weight loss [4].”
BackgroundThe Epidemiology of Obesity: A Big Picture
Hruby, A., & Hu, F. B. (2015) · PharmacoEconomics · doi:10.1007/s40273-014-0243-x · Cited by 2,916 · cited 2×
“…with obesity is constantly growing, with approximately 38% and 20% of world’s adult population to be overweight and obese by 2030, respectively, and the proportion of population with overweight and obesity is anticipated to be even higher at approximately over 85% in the United States [2].”
BackgroundChildhood obesity: causes and consequences
Bhadoria, A., Sahoo, K., Sahoo, B., Choudhury, A., Sofi, N., & Kumar, R. (2015) · Journal of Family Medicine and Primary Care · doi:10.4103/2249-4863.154628 · Cited by 1,985
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665 · cited 1×
“Obesity has a clear correlation with the incidence of cardiovascular disorders including hypertension, coronary artery disease, heart failure and sudden death, and many patients with insulin resistance, the main etiology of T2DM, tend to have high triglyceride and low HDL levels [53–55].”
BackgroundImpact of intermittent fasting on health and disease processes
Mattson, M. P., Longo, V. D., & Harvie, M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.10.005 · Cited by 1,187 · cited 1×
“Besides, inducing starvation via dietary regimens of alternate-day fasting [38] or intermittent fasting [39] has shown to reduce caloric intake and improve health markers related to cardiovascular risk in populations irrespective of obesity status.”
BackgroundPi-Sunyer, X. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.11.2074 · Cited by 1,025 · cited 1×
“…with the increasing prevalence and severity, obesity plays as a major underlying risk factor for chronic disorders, such as type 2 diabetes mellitus (T2DM), cardiovascular disorders, metabolic syndromes, chronic renal disorders, and malignancies, consequently increasing morbidity and mortality [1].”
BackgroundUse of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Nordmann, A. J., Nordmann, A., Briel, M., Keller, U., Yancy, W. S., Brehm, B. J., & Bucher, H. C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.285 · Cited by 973
Maintenance of Lost Weight and Long-Term Management of Obesity
Hall, K. D., & Kahan, S. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.012 · Cited by 876 · cited 1×
“Many patients with obesity start with a low-fat diet, which is composed of a relatively large amount of carbohydrates, because fats contain the highest calories among macronutrients [5,6].”
BackgroundPi-Sunyer, F. X. (2002) · Obesity Surgery · doi:10.1007/bf03342140 · Cited by 827
Bueno, N. B., de Melo, I. S. V., de Oliveira, S. L., & da Rocha Ataide, T. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513000548 · Cited by 778 · cited 2×
“Interestingly, a previous meta-analysis [46] displayed much more substantial weight loss with a long-term very-low carbohydrate ketogenic diet when compared with a low-fat diet, a conventional diet for weight loss, but the appropriateness of a long-term ketogenic diet for weight loss should be…”
BackgroundResultKossoff, E. H., Zupec‐Kania, B. A., Auvin, S., Ballaban‐Gil, K. R., Christina Bergqvist, A. G., Blackford, R., Buchhalter, J. R., Caraballo, R. H., Cross, J. H., Dahlin, M. G., et al. (2018) · Epilepsia Open · doi:10.1002/epi4.12225 · Cited by 768 · cited 2×
“Ketogenic diets have been recommended as nonpharmacological treatment for medication-refractory epilepsy in children and adults since 1921 [8,9].”
Background5. Lifestyle Management:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s005 · Cited by 700 · cited 1×
“However, ADA highly stresses the importance of individualized dietary plans based on personal eating patterns, preferences and metabolic goals because a low-carbohydrate high-fat diet may have some issues with long-term sustainability [51].”
BackgroundMechanisms of insulin resistance in obesity
Ye, J. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0262-6 · Cited by 699 · cited 1×
“…and hyperinsulinemia secondary to diminished insulin excretion via the kidney and the liver along with increased insulin production resulting from the increased number of pancreatic beta-cells, and weight loss is reported to attenuate or reverse obesity-induced insulin resistance [48,49].”
BackgroundMadeo, F., Carmona-Gutierrez, D., Hofer, S. J., & Kroemer, G. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.018 · Cited by 630
Calorie restriction in humans: An update
Most, J., Tosti, V., Redman, L. M., & Fontana, L. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.005 · Cited by 530 · cited 1×
“Recent studies [36,37] suggested that caloric restriction without malnutrition, the cornerstone of weight loss, may help to extend lifespan by preventing age-associated pathogenesis.”
BackgroundAnticonvulsant Mechanisms of the Ketogenic Diet
Bough, K. J., & Rho, J. M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00915.x · Cited by 523 · cited 2×
“A ketogenic diet, on the other hand, is a high-fat, low-carbohydrate diet, limiting carbohydrate intake to 5% to 10% of total daily dietary requirements and replacing the remaining with dietary fat and adequate protein (1g / kg) [7].”
BackgroundWestman, E. C., Yancy, W. S., Mavropoulos, J. C., Marquart, M., & McDuffie, J. R. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-36 · Cited by 475
Johnstone, A. M., Horgan, G. W., Murison, S. D., Bremner, D. M., & Lobley, G. E. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.44 · Cited by 440
Position of the American Dietetic
Cummings, S., Parham, E. S., & Strain, G. W. (2002) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(02)90255-5 · Cited by 432 · cited 1×
“Thus, the importance of a proper diet cannot be neglected in chronic disease prevention and management, and various dietary plans including a conventional diet for weight loss are currently available for weight loss or prevention of obesity-associated disorders [35].”
BackgroundStekovic, S., Hofer, S. J., Tripolt, N., Aon, M. A., Royer, P., Pein, L., Stadler, J. T., Pendl, T., Prietl, B., Url, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.016 · Cited by 412 · cited 1×
“Besides, inducing starvation via dietary regimens of alternate-day fasting [38] or intermittent fasting [39] has shown to reduce caloric intake and improve health markers related to cardiovascular risk in populations irrespective of obesity status.”
BackgroundHallberg, S. J., McKenzie, A. L., Williams, P. T., Bhanpuri, N. H., Peters, A. L., Campbell, W. W., Hazbun, T. L., Volk, B. M., McCarter, J. P., Phinney, S. D., et al. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0373-9 · Cited by 406
Hession, M., Rolland, C., Kulkarni, U., Wise, A., & Broom, J. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00518.x · Cited by 392 · cited 1×
“…we analyzed the impact of a ketogenic diet on lipid controls and cardiovascular risk markers and found similar results to previous studies [46,56,57] that evaluated the e ff ects of a low-carbohydrate diet; our analysis revealed that a ketogenic diet decreased triglycerides while increasing…”
ResultKetogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy
Lefevre, F., & Aronson, N. (2000) · Pediatrics · doi:10.1542/peds.105.4.e46 · Cited by 331 · cited 2×
“Ketogenic diets have been recommended as nonpharmacological treatment for medication-refractory epilepsy in children and adults since 1921 [8,9].”
BackgroundKetogenic Diet in Alzheimer’s Disease
Rusek, M., Pluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163892 · Cited by 319 · cited 1×
“Moreover, the neuroprotective e ff ects of the ketogenic diet have also been reported in studies, which would benefit patients with Alzheimer’s or Parkinson’s disease [42,43].”
BackgroundRole of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)
Włodarek, D. (2019) · Nutrients · doi:10.3390/nu11010169 · Cited by 301 · cited 1×
“Moreover, the neuroprotective e ff ects of the ketogenic diet have also been reported in studies, which would benefit patients with Alzheimer’s or Parkinson’s disease [42,43].”
BackgroundPosition of the American Dietetic Association: Weight Management
(2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.11.041 · Cited by 285
Sainsbury, E., Kizirian, N. V., Partridge, S. R., Gill, T., Colagiuri, S., & Gibson, A. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.026 · Cited by 268
Saslow, L. R., Mason, A. E., Kim, S., Goldman, V., Ploutz-Snyder, R., Bayandorian, H., Daubenmier, J., Hecht, F. M., & Moskowitz, J. T. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.5806 · Cited by 265 · cited 3×
“Our meta-analysis for glycemic control incorporated 4 studies [27,28,30,34] that had intervention duration of at least 8 months or longer, and hence, further study on long-term sustainability along with long-term benefits of a ketogenic diet in glycemic control is warranted.”
BackgroundMethodAccurso, A., Bernstein, R. K., Dahlqvist, A., Draznin, B., Feinman, R. D., Fine, E. J., Gleed, A., Jacobs, D. B., Larson, G., Lustig, R. H., et al. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-9 · Cited by 263 · cited 1×
“Considering low HDL and high triglyceride levels being independent risk factors for insulin resistance and cardiovascular disorders [58], our analysis suggested that a ketogenic diet has cardioprotective e ff ects in diabetic patients as the e ff ects of a ketogenic diet on triglyceride and HDL were…”
BackgroundGoday, A., Bellido, D., Sajoux, I., Crujeiras, A. B., Burguera, B., García-Luna, P. P., Oleaga, A., Moreno, B., & Casanueva, F. F. (2016) · Nutrition & Diabetes · doi:10.1038/nutd.2016.36 · Cited by 258
Saslow, L. R., Daubenmier, J. J., Moskowitz, J. T., Kim, S., Murphy, E. J., Phinney, S. D., Ploutz-Snyder, R., Goldman, V., Cox, R. M., Mason, A. E., et al. (2017) · Nutrition & Diabetes · doi:10.1038/s41387-017-0006-9 · Cited by 241 · cited 3×
“We combined data for other cardiovascular and renal risk markers, including SBP, DBP, CRP and SCr, reported in six studies [24,26,27,30,32,34].”
BackgroundMethodNutritional ketosis for weight management and reversal of metabolic syndrome
Gershuni, V. M., Yan, S. L., & Medici, V. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0235-0 · Cited by 239 · cited 2×
“Recently, some studies advocated the beneficial e ff ects of the ketogenic diet in weight management and prevention of metabolic syndrome by inducing nutritional ketosis [15].”
BackgroundOverweight and diabetes prevention: Is a low-carbohydrate-high-fat diet recommendable?
Brouns, F. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1636-y · Cited by 235 · cited 2×
“Carbohydrate restriction to less than 50 g per day triggers gluconeogenesis and ketogenesis in the liver, production of ketone bodies such as acetoacetic acid and beta-hydroxybutyric acid from fatty acids in replacement of glucose [44].”
BackgroundLow-Carb and Ketogenic Diets in Type 1 and Type 2 Diabetes
Bolla, A. M., Caretto, A., Laurenzi, A., Scavini, M., & Piemonti, L. (2019) · Nutrients · doi:10.3390/nu11050962 · Cited by 226 · cited 1×
“Moreover, ketogenic diets were indeed the principal therapeutic option for diabetes before the discovery of insulin in the early 20th century [11,12].”
BackgroundSaslow, L. R., Kim, S., Daubenmier, J. J., Moskowitz, J. T., Phinney, S. D., Goldman, V., Murphy, E. J., Cox, R. M., Moran, P., & Hecht, F. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091027 · Cited by 221 · cited 3×
“experience a post the dietary intervention [21,24,26–29, greater ].”
BackgroundMethodInfluentialTay, J., Thompson, C. H., Luscombe‐Marsh, N. D., Wycherley, T. P., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13164 · Cited by 215
Diabetes and Cancer: a Review of Current Knowledge
Wojciechowska, J., Krajewski, W., Bolanowski, M., Kręcicki, T., & Zatoński, T. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-100910 · Cited by 212 · cited 1×
“…in recent studies because diabetes-specific factors including insulin resistance, hyperglycemia, and hyperinsulinemia, which can be reversed by a ketogenic diet as shown in our study, play as biological links to site-specific malignancies, especially in breast, lung, kidney, and pancreas [60–62].”
BackgroundThe ketogenic diet and brain metabolism of amino acids: Relationship to the anticonvulsant effect
Yudkoff, M., Daikhin, Y., Melø, T. M., Nissim, I., Sonnewald, U., & Nissim, I. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093722 · Cited by 202
Long-term effects of a ketogenic diet in obese patients.
Dashti, H. M., Mathew, T. C., Hussein, T., Asfar, S., Behbahani, A. I., Khoursheed, M., Al-Sayer, H. M., Bo-Abbas, Y. Y., & Al-Zaid, N. S. (2004) · PubMed · Cited by 191
Updated review on the benefits of weight loss
Vidal, J. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802215 · Cited by 188
A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss
Yancy, W. S., Westman, E. C., McDuffie, J. R., Grambow, S. C., Jeffreys, A. S., Bolton, J., Chalecki, A., & Oddone, E. Z. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.492 · Cited by 165 · cited 5×
“We combined data for other cardiovascular and renal risk markers, including SBP, DBP, CRP and SCr, reported in six studies [24,26,27,30,32,34].”
BackgroundMethodInfluentialImpact of dietary fats on brain functions
Chianese, R., Coccurello, R., Viggiano, A., Scafuro, M., Fiore, M., Coppola, G., Operto, F. F., Fasano, S., Laye, S., Pierantoni, R., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171017102547 · Cited by 159 · cited 1×
“The exact mechanism of its anticonvulsive activity is still under debate; however, dietary fatty acids, including omega-6 and omega-3 long chain polyunsaturated fatty acids, have shown to regulate signal-transduction pathways in the brain [41].”
BackgroundKlement, R. J. (2017) · Medical Oncology · doi:10.1007/s12032-017-0991-5 · Cited by 159
Triglycerides and HDL Cholesterol
Bitzur, R., Cohen, H., Kamari, Y., Shaish, A., & Harats, D. (2009) · Diabetes Care · doi:10.2337/dc09-s343 · Cited by 132 · cited 1×
“Obesity has a clear correlation with the incidence of cardiovascular disorders including hypertension, coronary artery disease, heart failure and sudden death, and many patients with insulin resistance, the main etiology of T2DM, tend to have high triglyceride and low HDL levels [53–55].”
Diet in the management of weight loss
Strychar, I. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.045037 · Cited by 129 · cited 1×
“Many patients with obesity start with a low-fat diet, which is composed of a relatively large amount of carbohydrates, because fats contain the highest calories among macronutrients [5,6].”
BackgroundWestman, E. C., Yancy, W. S., Olsen, M. K., Dudley, T., & Guyton, J. R. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.08.034 · Cited by 115 · cited 1×
“Interestingly, the study conducted by Westman et al. [59] showed that a ketogenic diet changed the composition of LDL subclasses, increasing the proportion of large-sized buoyant LDL with cardiovascular protective e ff ects while significantly decreasing small-sized dense LDL, which is the primary…”
MethodMyette‐Côté, É., Durrer, C. G., Neudorf, H., Bammert, T. D., Botezelli, J. D., Johnson, J. D., DeSouza, C. A., & Little, J. P. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00240.2018 · Cited by 114 · cited 6×
“…( p = 0.10). potential confounding effects owing to heterogeneity across RCTs, we performed an additional analysis after excluding two RCTs [23,25] from meta-analysis for relatively More detailed information about these analysis results can be found in Supplementary Material (Figure S1).…”
BackgroundMethodInfluentialPartsalaki, Karvela, A., & Spiliotis, B. E. (2012) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0131 · Cited by 107 · cited 3×
“experience a post the dietary intervention [21,24,26–29, greater ].”
BackgroundMethodInfluentialJabekk, P. T., Moe, I. A., Meen, H. D., Tomten, S. E., & Høstmark, A. T. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-17 · Cited by 85
Why were "starvation diets" promoted for diabetes in the pre-insulin period?
Mazur, A. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-23 · Cited by 84 · cited 1×
“Moreover, ketogenic diets were indeed the principal therapeutic option for diabetes before the discovery of insulin in the early 20th century [11,12].”
BackgroundAcid-base analysis of individuals following two weight loss diets
Yancy, W. S., Olsen, M. K., Dudley, T. K., & Westman, E. C. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602661 · Cited by 51
Sun, S., Kong, Z., Shi, Q., Hu, M., Zhang, H., Zhang, D., & Nie, J. (2019) · Nutrients · doi:10.3390/nu11123051 · Cited by 44 · cited 2×
“experience a post the dietary intervention [21,24,26–29, greater ].”
BackgroundInfluentialKetogenic Diets and Cancer: Emerging Evidence
Tan-Shalaby, J. L. (2017) · Federal Practitioner · doi:10.12788/fp.0457 · Cited by 41 · cited 1×
“…in recent studies because diabetes-specific factors including insulin resistance, hyperglycemia, and hyperinsulinemia, which can be reversed by a ketogenic diet as shown in our study, play as biological links to site-specific malignancies, especially in breast, lung, kidney, and pancreas [60–62].”
BackgroundLipolysis and gluconeogenesis from glycerol during weight reduction with very-low-calorie diets
Vázquez, J. A., & Kazi, U. (1994) · Metabolism · doi:10.1016/0026-0495(94)90225-9 · Cited by 39
Sanz‐París, A., Calvo, L., Guallard, A., Salazar, I., & Albero, R. (1998) · Nutrition · doi:10.1016/s0899-9007(98)00124-5 · Cited by 37 · cited 5×
“…of potential confounding e ff ects owing to heterogeneity across RCTs, we performed an additional analysis after excluding two RCTs [23,25] from meta-analysis for relatively short-term follow-up [23,25] and antihyperglycemic use on the day of serum sampling for glucose and insulin measurement [25].”
BackgroundMethodInfluentialKang, X., Wang, C., Lifang, L., Chen, D., Yang, Y., Liu, G., Wen, H., Chen, L., He, L., Li, X., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0305 · Cited by 36
CARROLL, J., & Koenigsberger, D. Y. (1998) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(98)00074-1 · Cited by 32
Research works printed but not linked: 1
- Osler, 1923, Diabetes mellitus, The Principles and Practice of Medicine, Volume 1, 421
Cited by
Obesity Management in Adults: A Review
Elmaleh-Sachs, A., Schwartz, J. L., Bramante, C. T., Nicklas, J. M., Gudzune, K. A., & Jay, M. (2023) · JAMA · doi:10.1001/jama.2023.19897 · Cited by 813
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 399
“Similarly, a meta-analysis of randomized controlled trials (RCTs) demonstrated that, compared to low-fat diets, KD more effectively improved the metabolic parameters associated with glycemic, weight, and lipid control in obese participants, especially those with preexisting diabetes.(117) Plasma lipids constitute the…”
MethodKetone bodies: from enemy to friend and guardian angel
Kolb, H., Kempf, K., Röhling, M., Lenzen-Schulte, M., Schloot, N. C., & Martin, S. (2021) · BMC Medicine · doi:10.1186/s12916-021-02185-0 · Cited by 361
“All metabolic effects of ketogenic diets were similar in obese nondiabetic study participants, but of lower magnitude [102].”
BackgroundThe Role of Ketogenic Diet in the Treatment of Neurological Diseases
Dyńka, D., Kowalcze, K., & Paziewska, A. (2022) · Nutrients · doi:10.3390/nu14235003 · Cited by 215
“Taking into account the strongly hypoglycaemic effect of a ketogenic diet and the evident insulin-concentration-reducing effect [51,52], it seems reasonable that a ketogenic diet would have a favourable effect on the prevention of the deposition of amyloid plaques or a reduction in their number.”
BackgroundVancells Lujan, P., Viñas Esmel, E., & Sacanella Meseguer, E. (2021) · Nutrients · doi:10.3390/nu13051442 · Cited by 209
“of total daily caloric intake (20–50 g of carbohydrate/day) [133], although the specific macronutrient composition may vary.”
Background
Metadata
- Authors
- Choi, Y. J., Jeon, S.-M., & Shin, S.
- Affiliations
- Hallym University Medical Center (KR)
- Ajou University (KR)
- Corresponding author
- Shin, Sooyoung
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-07-06
- Volume
- 12
- Issue
- 7
- Pages
- 2005
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7400909
- OpenAlex
- W3038345563
- Semantic Scholar
- c9e4dfc137872628059f83f074d65d093a6e4861
- Cited by
- 193
- References
- 64
- Citations by year
- 2026: 19 · 2025: 32 · 2024: 40 · 2023: 46 · 2022: 40 · 2021: 14 · 2020: 2
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Research Foundation
- Ajou University
- Korea Health Industry Development Institute (HI17C0640)
- National Research Foundation of Korea (2017R1C1B5015912)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- ketogenic diet, obesity, overweight, type 2 diabetes, glycemic control, HbA1c, HOMA-IR, weight loss, lipid profile, triglycerides, HDL cholesterol, metabolic parameters
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Body Weight, Diabetes Mellitus, Type 2, Female, Humans, Lipids, Male, Middle Aged, Obesity, Randomized Controlled Trials as Topic, Overweight, Diet, Ketogenic, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.